Form 8-K - Current report:
SEC Accession No. 0001104659-25-077575
Filing Date
2025-08-13
Accepted
2025-08-13 16:15:30
Documents
14
Period of Report
2025-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523360d1_8k.htm   iXBRL 8-K 26564
2 EXHIBIT 99.1 tm2523360d1_ex99-1.htm EX-99.1 99708
6 GRAPHIC tm2523360d1_ex99-1img001.jpg GRAPHIC 8495
  Complete submission text file 0001104659-25-077575.txt   318677

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hypd-20250813.xsd EX-101.SCH 3026
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hypd-20250813_lab.xml EX-101.LAB 34915
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hypd-20250813_pre.xml EX-101.PRE 22796
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2523360d1_8k_htm.xml XML 3857
Mailing Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653
Business Address 23461 SOUTH POINTE DRIVE, SUITE 390 LAGUNA HILLS CA 92653 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 251211826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)